Meningococcal B vaccine development and evaluation of efficacy
- PMID: 18388494
- DOI: 10.4161/hv.4.2.4871
Meningococcal B vaccine development and evaluation of efficacy
Abstract
In this commentary we stress that serum bactericidal activity is now internationally accepted as correlate of protection for evaluating new vaccines for epidemic and endemic meningococcal B control, and that the standardization of the assay and the choice of representative strains for each of the vaccine candidates are critical.
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical